New Key Statistics Module, Z-Score and F-Score
SGX:RXS Key Ratios
| Market Cap S$ M | 68.06 |
| Enterprise Value S$ M | 46.97 |
| P/E(ttm) | 1.47 |
| PE Ratio without NRI | 1.42 |
| Forward PE Ratio | 0.72 |
| Price/Book | 0.72 |
| Price/Sales | 0.63 |
| Price/Free Cash Flow | 4.27 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) S$ M | 42.00 |
| EPS (TTM) S$ | 0.03 |
| Beneish M-Score | -2.09 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -96.70 |
| EV-to-EBIT | 2.15 |
| EV-to-EBITDA | 1.80 |
| PEG | -- |
| Shares Outstanding M | 1,447.99 |
| Net Margin (%) | 46.06 |
| Operating Margin % | 48.24 |
| Pre-tax Margin (%) | 49.03 |
| Quick Ratio | 1.70 |
| Current Ratio | 1.70 |
| ROA % (ttm) | 13.15 |
| ROE % (ttm) | 34.60 |
| ROIC % (ttm) | 20.47 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.05 |
SGX:RXS Number of Guru Trades
SGX:RXS Volume of Guru Trades
Gurus Latest Trades with SGX:RXS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SGX:RXS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers